Two Sigma Advisers LP Acquires 10,300 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Two Sigma Advisers LP boosted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 50.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,900 shares of the company's stock after acquiring an additional 10,300 shares during the period. Two Sigma Advisers LP owned approximately 0.20% of U.S. Physical Therapy worth $2,741,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. HighTower Advisors LLC raised its stake in shares of U.S. Physical Therapy by 2.5% in the fourth quarter. HighTower Advisors LLC now owns 4,833 shares of the company's stock valued at $429,000 after purchasing an additional 119 shares in the last quarter. CBIZ Investment Advisory Services LLC grew its position in U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after acquiring an additional 122 shares during the period. Aquatic Capital Management LLC grew its holdings in shares of U.S. Physical Therapy by 18.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock worth $115,000 after purchasing an additional 198 shares during the last quarter. Norden Group LLC increased its position in shares of U.S. Physical Therapy by 4.8% during the 4th quarter. Norden Group LLC now owns 5,139 shares of the company's stock worth $456,000 after purchasing an additional 235 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in U.S. Physical Therapy by 3.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,506 shares of the company's stock valued at $755,000 after purchasing an additional 282 shares during the last quarter.

U.S. Physical Therapy Stock Down 0.9%

Shares of NYSE USPH traded down $0.71 during trading hours on Friday, hitting $74.89. The company had a trading volume of 94,708 shares, compared to its average volume of 112,098. The stock has a market capitalization of $1.14 billion, a P/E ratio of 79.67, a price-to-earnings-growth ratio of 3.54 and a beta of 1.44. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $102.89. The firm's 50 day moving average is $72.02 and its 200-day moving average is $82.59. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping the consensus estimate of $0.46 by $0.02. The company had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm's revenue for the quarter was up 18.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.51 EPS. On average, analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be given a $0.45 dividend. The ex-dividend date is Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.40%. U.S. Physical Therapy's payout ratio is presently 82.57%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. The trade was a 19.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on USPH shares. JPMorgan Chase & Co. cut their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Wednesday, March 19th. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Barrington Research decreased their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. JMP Securities restated a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, Wall Street Zen raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $109.00.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.